Geopolitical Risks Threaten Pharma Supply Chains in 2026
Get tomorrow's supply chain signal
Daily supply-chain brief. Free, unsubscribe anytime.
The signal
DSV's assessment of pharmaceutical supply chain vulnerabilities for 2026 highlights escalating geopolitical tensions as a structural risk to drug manufacturing, ingredient sourcing, and distribution networks globally.
The outlook signals that political instability, trade restrictions, and regional conflicts will increasingly disrupt the flow of active pharmaceutical ingredients (APIs) and finished pharmaceuticals across traditional supply corridors, forcing companies to reconsider their sourcing geography and logistics strategies.
For supply chain professionals, this represents a shift from optimizing for cost and efficiency to building resilience into network design—requiring investment in dual-sourcing strategies, nearshoring capabilities, and enhanced visibility into geopolitical risk factors that can trigger supply disruptions with minimal warning.
Frequently Asked Questions
What This Means for Your Supply Chain
What if a key API supplier in a geopolitically sensitive region becomes unavailable for 8 weeks?
Model the impact of losing a major active pharmaceutical ingredient supplier due to geopolitical sanctions, export controls, or regional conflict for 2 months. Simulate the ability to fulfill drug manufacturing commitments by shifting production to secondary suppliers, adjusting lead times, and managing inventory drawdowns across the network.
Run this scenarioWhat if political instability forces pharmaceutical companies to nearshore 30% of API production?
Evaluate the supply chain transformation required to move 30% of active pharmaceutical ingredient production from geopolitically high-risk regions to nearshore hubs. Simulate the lead time changes, cost impacts (higher labor, lower volume economies), capacity constraints, and timeline to achieve operational stability in new facilities.
Run this scenarioWhat if new export controls increase pharma logistics costs by 15-20%?
Simulate the financial and operational impact of geopolitical sanctions or export controls that increase compliance costs, require alternative shipping routes, or mandate higher-cost logistics partners. Model how increased lead times and transportation expenses ripple through pricing, margin pressure, and service level agreements.
Run this scenarioGet the daily supply chain briefing
Top stories, Pulse score, and disruption alerts. No spam. Unsubscribe anytime.